Identification and characterization of solid-state nature of 2-chloromandelic acid

Journal of Pharmaceutical Sciences

Volumn 98, Issue 5, 2009, Pages 1835-1844

  He, Quan ^a   Zhu, Jesse ^a   Gomaa, Hassan ^a   Jennings, Michael ^a   Rohani, Sohrab ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

2 chloromandelic acid; Conglomerate; Crystal structure; Differential scanning calorimetry; Enantiomer; Melting point diagram; Racemate

Indexed keywords

2 CHLOROMANDELIC ACID; DRUG CARRIER; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; RACEMIC MIXTURE; SOLID STATE;

EID: 65949093281     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21560     Document Type: Article

References (28)

1. FDA's policy statement for the development of new stereoisomeric drugs 1992. Chirality 4:338-340.
2. Millership JS, Fitzpatrick A. 1993. Commonly used chiral drugs: A survey. Chirality 5:573-576.
3. Thayer A. 2005. Chiral catalysis. Chem Eng News 83:49-53.
4. Li ZJ, Zell MT, Munson EJ, Grant DJW. 1999. Characterization of racemic species of chiral drugs using thermal analysis, thermodynamic calculation, and structural studies. J Pharm Sci 88:337-346.
5. Lorenz H, Sheehan P, Seidel-Morgenstern A. 2001. Coupling of simulated moving bed chromatography and fractional crystallisation for efficient enantioseparation. J Chromatogr A 908:201-214.
6. Amanullah M, Mazzotti M. 2006. Optimization of a hybrid chromatography-crystallization process for the separation of Tröger's base enantiomers. J Chromatogr A 1107:36-45.
7. Jacques J, Collet A, Wilen SH. 1981. Enantiomers, racemates and resolutions. New York: Wiley.
8. Wang Y, Chen A. 2008. Enantioenrichment by crystallization. Org Process Res Dev 12:282-290.
9. Dwivedi SK, Sattari S, Jamali F, Mitchell AG. 1992. Ibuprofen racemate and enantiomers: Phase diagram, solubility and thermodynamic data. Int J Pharm 87:95-104.
10. Burger A, Rollinger JM, Bruggeller P. 1997. Binary system of (R)- and (S)-nitrendipine-polymorphism and structure. J Pharm Sci 86:674-679.
11. Zhang GZ, Paspal SYL, Suryanarayanan R, Grant DJW. 2003. Racemic species of sodium ibuprofen: Characterization and polymorphic relationships. J Pharm Sci 92:1356-1366.
12. Pallavicini M, Bolchi C, Furnagalli L. 2007. Enantiomer systems of carnitinamide inorganic salts: Introductory studies to a successful entrainment resolution. Tetrahedron Asymmetr 18:906-909.
13. Mitchell AG. 1998. Racemic drugs: Racemic mixture, racemic compound, or Pseudoracemate? J Pharm Sci 1:8-12.
14. Neau SH, Shinwari MK, Hellmuth EW. 1993. Melting point phase diagrams of free base and hydrochloride salts of bevantolol, pindolol and propranolol. Int J Pharm 999:303-310.
15. Elsabee M, Prankerd RJ. 1992. Solid-state properties of drugs: 3 differential scaning of calorimetry of chiral drugs mixtures existing as racemic solid solution, racemic mixture or racemic compounds. Int J Pharm 86:221-230.
16. Lorenz H, Seidel-Morgenstern A. 2004. A contribution to the mandelic acid phase diagram. Thermochimica 415:55-61.
17. Feliste R, Delebassee D, Simon MF, Chap HDG, Vallee E. 1987. Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP. Throm Res 8:403-415.
18. Testa B. 2004. Produrg research: Futile or fertile? Biochem Pharmacol 68:2097-2106.
19. He Q, Peng YF. 2004. Preparation of optically active o-chloromandelic acid. J East China Univ Sci Technol 30:339-342.
20. Wang PY, Chen TL, Tsai SW. 2006. Kinetic resolution of (R,S)-ethyl 2-chloromandelate in biphasic media using hydrolase of Klebsiella oxytoca. Enzyme Microb Technol 39:930-935.
21. Bauer T, Gajewiak J. 2005. α-Hydroxy carboxylic acids as ligands for enantioselective addition reactions of organoaluminum reagents to aromatic and aliphatic aldehydes. Tetrahedron Asymmetr 16:851-855.
22. van Langer LM, van Rantwijk F, Sheldon RA. 2003. Enzymatic hydrocyanation of a sterically hindered aldehyde, optimization of a chemoenzymatic procedure for (R)-2-chloromandelic acid. Org Process Res Dev 7:828-831.
23. Lorenz H, Sapoundjiev D, Seidel-Morgenstern A. 2002. Enantiomeric mandelic acid system - Melting point phase diagram and solubility in water. J Chem Eng Data 47:1280-1284.
24. "Collect" data collection software, Nonius B.V., 1999.
25. Otwinowski Z, Minor W. 1997. Processing of X-ray Diffraction Data Collected in Oscillation Mode, Methods in Enzymology. Macromolecular Crystallography, part A 276: 307-326. C. W. Carter, Jr. & R. M. Sweet Eds., Academic Press.
26. Sheldrick GM. 2008. A short history of SHELX. Acta Crystall A64:112-122.
27. Coquerel G. 2007. Preferential Crystallization. Top Curr Chem 269:1-51.
28. Gallis HE, Miltenburg JC, Oonk HAJ. 2000. Polymorphism of mixtures of enantiomers: A thermodynamic study of mixtures of D- and L-limonene. Phys Chem Chem Phys 2:5619-5623.